Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chromadex Corp CS (CDXC)

Chromadex Corp CS (CDXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 256,051
  • Shares Outstanding, K 75,309
  • Annual Sales, $ 83,570 K
  • Annual Income, $ -4,940 K
  • 60-Month Beta 1.99
  • Price/Sales 2.66
  • Price/Cash Flow N/A
  • Price/Book 9.74
Trade CDXC with:

Options Overview Details

View History
  • Implied Volatility 156.60% ( -40.87%)
  • Historical Volatility 136.94%
  • IV Percentile 46%
  • IV Rank 18.05%
  • IV High 623.59% on 01/23/24
  • IV Low 53.74% on 09/11/23
  • Put/Call Vol Ratio 0.29
  • Today's Volume 45
  • Volume Avg (30-Day) 194
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 3,200
  • Open Int (30-Day) 3,676

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.03
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.03
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.89 +17.65%
on 04/22/24
4.65 -26.88%
on 04/05/24
-0.16 (-4.49%)
since 03/22/24
3-Month
1.45 +134.48%
on 01/25/24
4.65 -26.88%
on 04/05/24
+1.94 (+132.88%)
since 01/24/24
52-Week
1.25 +172.00%
on 10/23/23
4.65 -26.88%
on 04/05/24
+2.03 (+148.18%)
since 04/24/23

Most Recent Stories

More News
ChromaDex (CDXC) Reports Q1 Loss, Tops Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of 40% and 16.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 3.40 (unch)
ALIM : 3.63 (+1.11%)
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Lags Revenue Estimates

Arcutis Biotherapeutics, Inc. (ARQT) delivered earnings and revenue surprises of -0.77% and 20.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

ARQT : 8.75 (+0.11%)
CDXC : 3.40 (unch)
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Tops Revenue Estimates

CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 59.88% and 165.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

CRSP : 55.65 (-1.35%)
CDXC : 3.40 (unch)
ChromaDex to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023

ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, May 10, 2023 at 4:30 p.m. ET to discuss...

CDXC : 3.40 (unch)
ChromaDex (CDXC) Reports Q4 Loss, Lags Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of 33.33% and 0.40%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 3.40 (unch)
ICVX : 15.31 (-0.91%)
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2022 Results

ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2022 financial results.

CDXC : 3.40 (unch)
ChromaDex to Participate at the 35th Annual ROTH Capital Partners Conference on March 13, 2023

ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced that senior management will participate at the 35 th annual ROTH Capital Partners...

CDXC : 3.40 (unch)
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: Should You Buy?

ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ANIP : 65.43 (-1.07%)
CDXC : 3.40 (unch)
Will ChromaDex (CDXC) Report Negative Earnings Next Week? What You Should Know

ChromaDex (CDXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDXC : 3.40 (unch)
BNGO : 0.7611 (-4.19%)
ChromaDex to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Wednesday, March 8, 2023

ChromaDex Corp. (NASDAQ:CDXC) (“the Company”), a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, March 8, 2023 at 4:30 p.m. ET to...

CDXC : 3.40 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is...

See More

Key Turning Points

3rd Resistance Point 3.86
2nd Resistance Point 3.75
1st Resistance Point 3.58
Last Price 3.40
1st Support Level 3.30
2nd Support Level 3.19
3rd Support Level 3.02

See More

52-Week High 4.65
Last Price 3.40
Fibonacci 61.8% 3.35
Fibonacci 50% 2.95
Fibonacci 38.2% 2.55
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar